GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cyxone AB (OSTO:CYXO) » Definitions » Cash Receipts from Fees and Commissions

Cyxone AB (OSTO:CYXO) Cash Receipts from Fees and Commissions


View and export this data going back to 2016. Start your Free Trial

What is Cyxone AB Cash Receipts from Fees and Commissions?

Cash Receipts from Fees and Commissions only applicable to companies reporting Cash Flow from Operations in direct method.


Cyxone AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cyxone AB (OSTO:CYXO) » Definitions » Cash Receipts from Fees and Commissions
Traded in Other Exchanges
N/A
Address
Hyllie Boulevard 34, Malmo, SWE, 215 32
Cyxone AB is a clinical biotech company with a portfolio of immunomodulating drugs for the treatment of autoimmune diseases such as multiple sclerosis (MS) and rheumatoid arthritis (RA). The product candidates of the company include T20K and Rabeximod.